ALARM SYSTEM THAT PROCESSES BOTH MOTION AND VITAL SIGNS USING SPECIFIC HEURISTIC RULES AND THRESHOLDS
20210251493 · 2021-08-19
Assignee
Inventors
- Devin McCOMBIE (Carlsbad, CA, US)
- Matt Banet (San Diego, CA, US)
- Marshal Dhillon (San Diego, CA)
- Jim Moon (San Diego, CA, US)
Cpc classification
G08B21/0446
PHYSICS
G16H50/20
PHYSICS
A61B5/02416
HUMAN NECESSITIES
A61B5/352
HUMAN NECESSITIES
A61B5/0816
HUMAN NECESSITIES
A61B5/349
HUMAN NECESSITIES
G08B21/0453
PHYSICS
A61B5/145
HUMAN NECESSITIES
A61B5/322
HUMAN NECESSITIES
A61B5/02438
HUMAN NECESSITIES
A61B5/02028
HUMAN NECESSITIES
G16H15/00
PHYSICS
A61B5/0205
HUMAN NECESSITIES
A61B5/7278
HUMAN NECESSITIES
A61B5/0245
HUMAN NECESSITIES
A61B5/0022
HUMAN NECESSITIES
A61B5/0059
HUMAN NECESSITIES
A61B5/7246
HUMAN NECESSITIES
A61B5/318
HUMAN NECESSITIES
A61B5/11
HUMAN NECESSITIES
A61B5/022
HUMAN NECESSITIES
A61B5/1123
HUMAN NECESSITIES
A61B5/02055
HUMAN NECESSITIES
A61B5/721
HUMAN NECESSITIES
A61B5/746
HUMAN NECESSITIES
A61B2562/0219
HUMAN NECESSITIES
International classification
A61B5/0205
HUMAN NECESSITIES
A61B5/00
HUMAN NECESSITIES
A61B5/02
HUMAN NECESSITIES
A61B5/022
HUMAN NECESSITIES
A61B5/11
HUMAN NECESSITIES
A61B5/318
HUMAN NECESSITIES
G16H15/00
PHYSICS
Abstract
The invention provides a body-worn monitor that measures a patient's vital signs (e.g. blood pressure, SpO2, heart rate, respiratory rate, and temperature) while simultaneously characterizing their activity state (e.g. resting, walking, convulsing, falling). The body-worn monitor processes this information to minimize corruption of the vital signs by motion-related artifacts. A software framework generates alarms/alerts based on threshold values that are either preset or determined in real time. The framework additionally includes a series of ‘heuristic’ rules that take the patient's activity state and motion into account, and process the vital signs accordingly. These rules, for example, indicate that a walking patient is likely breathing and has a regular heart rate, even if their motion-corrupted vital signs suggest otherwise.
Claims
1. A system for monitoring a plurality of hospitalized patients, comprising: a plurality of body-worn monitoring systems, wherein each body-worn monitoring system in the plurality of body-worn monitoring systems is uniquely associated with a patient in the plurality of hospitalized patients, and wherein each body-worn monitoring system in the plurality of body-worn monitoring systems comprises a microprocessor operably connected to each of a PPG sensor, an ECG sensor, and at least two three-axis accelerometers to receive therefrom on a continuous basis a photoplethysmogram waveform, an ECG waveform, and three accelerometer waveforms from each three-axis accelerometer, and determine therefrom on a continuous basis a heart rate value, a blood pressure value, an SpO.sub.2 value, and a motion parameter indicative of patient posture and motion, and to determine an alarm rule indicating whether or not the patient requires attention by collectively processing the heart rate value, the blood pressure value, the SpO.sub.2 value, and the motion parameter, wherein each body-worn monitoring system in the plurality of body-worn monitoring systems is configured to communicate over a wireless network within the hospital; a data server operably connected to the wireless network and configured to receive from each body-worn monitoring system in the plurality of body-worn monitoring systems data corresponding to the heart rate value, the blood pressure value, the SpO.sub.2 value, the patient posture and motion, the photoplethysmogram waveform, the ECG waveform, the accelerometer waveforms, and the alarm rule, and associate the data received with the corresponding patient in the plurality of hospitalized patients; and a monitor operably connected to the server and, for one or more patients in the plurality of patients, configured to receive from the server on a continuous basis the heart rate value, the blood pressure value, the SpO.sub.2 value, the patient posture and motion for the corresponding patient, and the alarm rule, and display the heart rate value, the blood pressure value, the SpO.sub.2 value, an icon indicating patient posture and motion, and an icon indicating whether or not the patient requires attention based on the alarm rule.
Description
BRIEF DESCRIPTION OF THE DRAWINGS
[0032]
[0033]
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042]
[0043]
[0044]
[0045]
[0046]
[0047]
[0048]
[0049]
[0050]
[0051]
[0052]
[0053]
[0054]
[0055]
[0056]
[0057]
DETAILED DESCRIPTION OF THE INVENTION
[0058] System Overview
[0059]
[0060] The ECG 16 and pneumatic 20 systems are stand-alone systems that include a separate microprocessor and analog-to-digital converter. During a measurement, they connect to the transceiver 12 through connectors 28, 30 and supply digital inputs using a communication protocol that runs on a controller-area network (CAN) bus. The CAN bus is a serial interface, typically used in the automotive industry, which allows different electronic systems to effectively communicate with each other, even in the presence of electrically noisy environments. A third connector 32 also supports the CAN bus and is used for ancillary medical devices (e.g. a glucometer) that is either worn by the patient or present in their hospital room.
[0061] The optical system 18 features an LED and photodetector and, unlike the ECG 16 and pneumatic 20 systems, generates an analog electrical signal that connects through a cable 36 and connector 26 to the transceiver 12. As is described in detail below, the optical 18 and ECG 16 systems generate synchronized time-dependent waveforms that are processed with the composite technique to determine a PTT-based blood pressure along with motion information.
[0062] The first accelerometer 14a is surface-mounted on a printed circuited board within the transceiver 12, which is typically worn on the patient's wrist like a watch. The second 14b accelerometer is typically disposed on the upper portion of the patient's arm and attaches to a cable 40 that connects the ECG system 16 to the transceiver 12. The third accelerometer 14c is typically worn on the patient's chest proximal to the ECG system 16. The second 14b and third 14c accelerometers integrate with the ECG system 16 into a single cable 40, as is described in more detail below, which extends from the patient's wrist to their chest and supplies digitized signals over the CAN bus. In total, the cable 40 connects to the ECG system 16, two accelerometers 14b, 14c, and at least three ECG electrodes (shown in
[0063] To determine posture, arm height, activity level, and degree of motion, the transceiver's CPU 22 processes signals from each accelerometer 14a-c with a series of algorithms, described in detail below. In total, the CPU can process nine unique, time-dependent signals (ACC.sub.1-9) corresponding to the three axes measured by the three separate accelerometers. Specifically, the algorithms determine parameters such as the patient's posture (e.g., sitting, standing, walking, resting, convulsing, falling), the degree of motion, the specific orientation of the patient's arm and how this affects vital signs (particularly blood pressure), and whether or not time-dependent signals measured by the ECG 16, optical 18, or pneumatic 20 systems are corrupted by motion. Once this is complete, the transceiver 12 uses an internal wireless transmitter 24 to send information in a series of packets, as indicated by arrow 34, to a remote monitor within a hospital. The wireless transmitter 24 typically operates on a protocol based on 802.11 and communicates with an existing network within the hospital. This information alerts a medical professional, such as a nurse or doctor, if the patient begins to decompensate. A server connected to the hospital network typically generates this alarm/alert once it receives the patient's vital signs, motion parameters, ECG, PPG, and ACC waveforms, and information describing their posture, and compares these parameters to preprogrammed threshold values. As described in detail below, this information, particularly vital signs and motion parameters, is closely coupled together. Alarm conditions corresponding to mobile and stationary patients are typically different, as motion can corrupt the accuracy of vital signs (e.g., by adding noise), and induce changes in them (e.g., through acceleration of the patient's heart and respiratory rates).
[0064] General Methodology for Alarms/Alerts
[0065] Algorithms operating on either the body-worn monitor or remote monitor generate alarms/alerts that are typically grouped into three general categories: 1) motion-related alarms/alerts indicating the patient is experiencing a traumatic activity, e.g. falling or convulsing; 2) life-threatening alarms/alerts typically related to severe events associated with a patient's cardiovascular or respiratory systems, e.g. asystole (ASY), ventricular fibrillation (VFIB), ventricular tachycardia (VTAC), and apnea (APNEA); and 3) threshold alarms/alerts generated when one of the patient's vital signs (SYS, DIA, SpO2, heart rate, respiratory rate, or temperature) exceeds a threshold that is either predetermined or calculated directly from the patient's vital signs. The general methodology for generating alarms/alerts in each of these categories is described in more detail below.
[0066] Motion-Related Alarms/Alerts
[0067]
[0068] The figures indicate that time-dependent properties of both ECG 50, 55, 60, 65 and PPG 51, 56, 61, 66 waveforms are strongly affected by motion, as indicated by the ACC waveforms 52, 57, 62, 67. Accuracy of the vital signs, such as SYS, DIA, heart rate, respiratory rate, and SpO2, calculated from these waveforms is therefore affected as well. Body temperature, which is measured from a separate body-worn sensor (typically a thermocouple) and does not rely on these waveforms, is relatively unaffected by motion.
[0069]
[0070]
[0071] The ECG waveform 55 measured from the walking patient is relatively unaffected by motion, other than indicating an increase in heart rate (i.e., a shorter time separation between neighboring QRS complexes) and respiratory rate (i.e. a higher frequency modulation of the waveform's envelope) caused by the patient's exertion. The PPG waveform 56, in contrast, is strongly affected by this motion, and becomes basically immeasurable. Its distortion is likely due to a quasi-periodic change in light levels, caused by the patient's swinging arm, and detected by the optical sensor's photodetector. Movement of the patient's arm additionally affects blood flow in the thumb and can cause the optical sensor to move relative to the patient's skin. The photodetector measures all of these artifacts, along with a conventional PPG signal (like the one shown in
[0072] The body-worn monitor deploys multiple strategies to avoid generating false alarms/alerts during a walking activity state. As described in detail below, the monitor can detect this state by processing the ACC waveforms shown in
TABLE-US-00001 TABLE 1A motion-dependent alarm/alert thresholds and heuristic rules for a walking patient Modified Motion Threshold for Heuristic Rules for Vital Sign State Alarms/Alerts Alarms/Alerts Blood Pressure Walking Increase Use Modified Threshold; (SYS, DIA) (+10-30%) Alarm/Alert if Value Exceeds Threshold Heart Rate Walking Increase Ignore Threshold; (+10-300%) Do Not Alarm/Alert Respiratory Walking Increase Ignore Threshold; Rate (+10-300%) Do Not Alarm/Alert SpO2 Walking No Change Ignore Threshold; Do Not Alarm/Alert Temperature Walking Increase Use Original Threshold; (+10-30%) Alarm/Alert if Value Exceeds Threshold
[0073] To further reduce false alarms/alerts, software associated with the body-worn monitor or remote monitor can deploy a series of heuristic rules determined beforehand using practical, empirical studies. These rules, for example, can indicate that a walking patient is likely healthy, breathing, and characterized by a normal SpO2. Accordingly, the rules dictate that respiratory rate and SpO2 values that are measured during a walking state and exceed predetermined alarm/alert thresholds are likely corrupted by artifacts; the system, in turn, does not sound the alarm/alert in this case. Heart rate, as indicated by
[0074]
[0075] Convulsing modulates the ACC waveform 62 due to rapid motion of the patient's arm, as measured by the wrist-worn accelerometer. This modulation is strongly coupled into the PPG waveform 61, likely because of the phenomena described above, i.e.: 1) ambient light coupling into the optical sensor's photodiode; 2) movement of the photodiode relative to the patient's skin; and 3) disrupted blow flow underneath the optical sensor. Note that from about 23-28 seconds the ACC waveform 62 is not modulated, indicating that the patient's arm is at rest. During this period the ambient light is constant and the optical sensor is stationary relative to the patient's skin. But the PPG waveform 61 is still strongly modulated, albeit at a different frequency than the modulation that occurred when the patient's arm was moving. This indicates modulation of the PPG waveform 61 is likely caused by at least the three factors described above, and that disrupted blood flow underneath the optical sensor continues even after the patient's arm stops moving. Using this information, both ECG and PPG waveforms similar to those shown in
[0076] The ECG waveform 60 is modulated by the patient's arm movement, but to a lesser degree than the PPG waveform 61. In this case, modulation is caused primarily by electrical ‘muscle noise’ instigated by the convulsion and detected by the ECG electrodes, and well as by convulsion-induced motion in the ECG cables and electrodes relative to the patient's skin. Such motion is expected to have a similar affect on temperature measurements, which are determined by a sensor that also includes a cable.
[0077] Table 1B, below, shows the modified threshold values and heuristic rules for alarms/alerts generated by a convulsing patient. In general, when a patient experiences convulsions, such as those simulated during the two 12-second periods in
TABLE-US-00002 TABLE 1B motion-dependent alarm/alert thresholds and heuristic rules for a convulsing patient Modified Motion Threshold for Vital Sign State Alarms/Alerts Heuristic Rules for Alarms/Alerts Blood Pressure Convulsing No Change Ignore Threshold; Generate (SYS, DIA) Alarm/Alert Because of Convulsion Heart Rate Convulsing No Change Ignore Threshold; Generate Alarm/Alert Because of Convulsion Respiratory Rate Convulsing No Change Ignore Threshold; Generate Alarm/Alert Because of Convulsion SpO2 Convulsing No Change Ignore Threshold; Generate Alarm/Alert Because of Convulsion Temperature Convulsing No Change Ignore Threshold; Generate Alarm/Alert Because of Convulsion
[0078] Table 1B also shows the heuristic rules for convulsing patients. Here, the overriding rule is that a convulsing patient needs assistance, and thus an alarm/alert for this patient is generated regardless of their vital signs (which, as described above, are likely inaccurate due to motion-related artifacts). The system always generates an alarm/alert for a convulsing patient.
[0079]
[0080] After a fall, both the ECG 65 and PPG 66 waveforms are free from artifacts, but both indicate an accelerated heart rate and relatively high heart rate variability for roughly 10 seconds. During this period the PPG waveform 66 also shows a decrease in pulse amplitude. Without being bound to any theory, the increase in heart rate may be due to the patient's baroreflex, which is the body's hemostatic mechanism for regulating and maintaining blood pressure. The baroreflex, for example, is initiated when a patient begins faint. In this case, the patient's fall may cause a rapid drop in blood pressure, thereby depressing the baroreflex. The body responds by accelerating heart rate (indicated by the ECG waveform 65) and increasing blood pressure (indicated by a reduction in PTT, as measured from the ECG 65 and PPG 66 waveforms) in order to deliver more blood to the patient's extremities.
[0081] Table 1C shows the heuristic rules and modified alarm thresholds for a falling patient. Falling, similar to convulsing, makes it difficult to measure waveforms and the vital signs calculated from them. Because of this and the short time duration associated with a fall, alarms/alerts based on vital signs thresholds are not generated when a patient falls. However, this activity, optionally coupled with prolonged stationary period or convulsion (both determined from the following ACC waveform), generates an alarm/alert according to the heuristic rules.
TABLE-US-00003 TABLE 1C motion-dependent alarm/alert thresholds and heuristic rules for a falling patient Modified Motion Threshold for Heuristic Rules for Vital Sign State Alarms/Alerts Alarms/Alerts Blood Pressure Falling No Change Ignore Threshold; Generate (SYS, DIA) Alarm/Alert Because of Fall Heart Rate Falling No Change Ignore Threshold; Generate Alarm/Alert Because of Fall Respiratory Falling No Change Ignore Threshold; Generate Rate Alarm/Alert Because of Fall SpO2 Falling No Change Ignore Threshold; Generate Alarm/Alert Because of Fall Temperature Falling No Change Ignore Threshold; Generate Alarm/Alert Because of Fall
[0082] As described in detail below, the patient's specific activity relates to both the time-dependent ACC waveforms and the frequency-dependent Fourier Transforms of these waveforms.
[0083] The ACC waveform corresponding to a resting patient (52 in
[0084]
[0085] Life-Threatening Alarms/Alerts
[0086] ASY and VFIB are typically determined directly from the ECG waveform using algorithms known in the art. To reduce false alarms associated with these events, the body-worn monitor calculates ASY and VFIB from the ECG waveform, and simultaneously determines a ‘significant pulse’ from both the PPG waveform and cNIBP measurement, described below. A significant pulse occurs when the monitor detects a pulse rate from the PPG waveform (see, for example, 51 in
[0087] The alarm/alert for ASY and VFIB additionally depends on the patient's activity level. For example, if the monitor determines ASY and VFIB from the ECG, and that the patient is walking from the ACC waveforms, it then checks for a significant pulse and determines pulse rate from the PPG waveform. In this situation the patient is assumed to be in an activity state prone to false alarms. The alarms/alerts related to ASY and VFIB are thus delayed, typically by 20-30 seconds, if the monitor determines the patient's pulse to be significant and their current pulse differs from their pulse rate measured during the previous 60 seconds by less than 40%. The monitor sounds an alarm only if ASY and VFIB remain after the delay period and once the patient stops walking. In another embodiment, an alarm/alert is immediately sounded if the monitor detects either ASY or VFIB, and no significant pulse is detected from the PPG waveform for between 5-10 seconds.
[0088] The methodology for alarms/alerts is slightly different for VTAC due to the severity of this condition. VTAC, like ASY and VFIB, is detected directly from the ECG waveform using algorithms know in the art. This condition is typically defined as five or more consecutive premature ventricular contractions (PVCs) detected from the patient's ECG. When VTAC is detected from the ECG waveform, the monitor checks for a significant pulse and compares the patient's current pulse rate to that measured during the entire previous 60 seconds. The alarm/alert related to VTAC is delayed, typically by 20-30 seconds, if the pulse is determined to be significant and the pulse rate measured during this period differs from patient's current pulse rate by less than 25%. The monitor immediately sounds an alarm/alert if VTAC measured from the ECG waveform meets the following criteria: 1) its persists after the delay period; 2) the deficit in the pulse rate increases to more than 25% at any point during the delay period; and 3) no significant pulse is measured for more than 8 consecutive seconds during the delay period. The alarm for VTAC is not generated if any of these criteria are not met.
[0089] APNEA refers to a temporary suspension in a patient's breathing and is determined directly from respiratory rate. The monitor measures this vital sign from the ECG waveform using techniques called ‘impedance pneumography’ or ‘impedance rheography’, both of which are known in the art. The monitor sounds an alarm/alert only if APNEA is detected and remains (i.e. the patient does not resume normal breathing) for a delay period of between 20-30 seconds.
[0090] The monitor does not sound an alarm/alert if it detects ASY, VFIB, VTAC, or APNEA from the ECG waveform and the patient is walking (or experiencing a similar motion that, unlike falling or convulsing, does not result in an immediate alarm/alert). The monitor immediately sounds an alarm during both the presence and absence of these conditions if it detects that the patient is falling, has fell and remains on the ground for more than 10 seconds, or is having a Grand-mal seizure or similar convulsion. These alarm criteria are similar to those described in the heuristic rules, above.
[0091] Threshold Alarms/Alerts
[0092] Threshold alarms are generated by comparing vital signs measured by the body-worn monitor to fixed values that are either preprogrammed or calculated in real time. These threshold values are separated, as described below, into both outer limits (OL) and inner limits (IL). The values for OL are separated into an upper outer limit (UOL) and a lower outer limit (LOL). Default values for both UOL and LOL are typically preprogrammed into the body-worn monitor during manufacturing, and can be adjusted by a medical professional once the monitor is deployed. Table 2, below, lists typical default values corresponding to each vital sign for both UOL and LOL.
[0093] Values for IL are typically determined directly from the patient's vital signs. These values are separated into an upper inner limit (UIL) and a lower inner limit (LIL), and are calculated from the UOL and LOL, an upper inner value (UIV), and a lower inner value (LIV). The UIV and LIV can either be preprogrammed parameters (similar to the UOL and LOL, described above), or can be calculated directly from the patient's vital signs using a simple statistical process described below:
UIL=UIV+(UOL−UIV)/3 [0094] (option A): UIV.fwdarw.preset factory parameter adjusted by medical professional [0095] (option B): UIV.fwdarw.1.3× weighted average of vital sign over previous 120 s
LIL=LIV+(LOL−LIV)/3 [0096] (option A): LIV.fwdarw.preset factory parameter adjusted by medical professional [0097] (option B): LIV.fwdarw.0.7× weighted average of vital sign over previous 120 s
[0098] In a preferred embodiment the monitor only sounds an alarm/alert when the vital sign of issue surpasses the UOL/LOL and the UIL/LIL for a predetermined time period. Typically, the time periods for the UOL/LOL are shorter than those for the UIL/LIL, as alarm limits corresponding to these extremities represent a relatively large deviation for normal values of the patient's vital signs, and are therefore considered to be more severe. Typically the delay time periods for alarms/alerts associated with all vital signs (other than temperature, which tends to be significantly less labile) are 10 s for the UOL/LOL, and 120-180 s for the UIL/LIL. For temperature, the delay time period for the UOL/LOL is typically 600 s, and the delay time period for the UIL/LIL is typically 300 s.
[0099] Other embodiments are also possible for the threshold alarms/alerts. For example, the body-worn monitor can sound alarms having different tones and durations depending if the vital sign exceeds the UOL/LOL or UIL/LIL. Similarly, the tone can be escalated (in terms of acoustic frequency, alarm ‘beeps’ per second, and/or volume) depending on how long, and by how much, these thresholds are exceeded. Alarms may also sound due to failure of hardware within the body-worn monitor, or if the monitor detects that one of the sensors (e.g. optical sensor, ECG electrodes) becomes detached from the patient.
TABLE-US-00004 TABLE 2 default alarm/alert values for UOL, UIV, LIV, and LOL Algorithm for Generating Alarms/Alerts Default Default Default Default Upper Upper Lower Lower Outer Inner Inner Outer Limit Value Value Limit Vital Sign (UOL) (UIV) (LIV) (LOL) Blood Pressure (SYS) 180 mmHg 160 mmHg 90 mmHg 80 mmHg Blood Pressure (MAP) 130 mmHg 120 mmHg 70 mmHg 60 mmHg Blood Pressure (DIA) 120 mmHg 110 mmHg 60 mmHg 50 mmHg Heart Rate 150 bpm 135 bpm 45 bpm 40 bpm Respiratory Rate 30 bmp 25 bmp 7 bpm 5 bpm SpO2 100% O2 90% O2 93% O2 85% O2 Temperature 103 deg. F. 101 deg. F. 95 deg. F. 96.5 deg. F.
[0100]
[0101] The first module 94 corresponds to a resting patient. In this state, the patient generates ECG, PPG, and ACC waveforms similar to those shown in
[0102] Method for Displaying Alarms/Alerts Using Graphical User Interfaces
[0103] Graphical user interfaces (GUI) operating on both the body-worn module and the remote monitor can render graphical icons that clearly identify the above-described patient activity states.
TABLE-US-00005 TABLE 3 description of icons shown in FIG. 9 and used in GUIs for both body-worn monitor and remote monitor Icon Activity State 105a Standing 105b Falling 105c resting; lying on side 105d Convulsing 105e Walking 105f Sitting 105g resting; lying on stomach 105h resting; lying on back
[0104]
[0105] The patient view 106 is designed to give a medical professional, such as a nurse or doctor, a quick, easy-to-understand status of all the patients of all the patients in the specific hospital area. In a single glance the medical professional can determine their patients' vital signs, measured continuously by the body-worn monitor, along with their activity state and alarm status. The view 106 features a separate area 108 corresponding to each patient. Each area 108 includes text fields describing the name of the patient and supervising clinician; numbers associated with the patient's bed, room, and body-worn monitor; and the type of alarm generated from the patient. Graphical icons, similar to those shown in
[0106]
[0107]
[0108] The medical professional view 126 is designed to have a look and feel similar to each area 108 shown in
[0109] Algorithms for Determining Patient Motion, Posture, Arm Height, Activity Level and the Effect of these Properties on Blood Pressure
[0110] Described below is an algorithm for using the three accelerometers featured in the above-described body-worn monitor to calculate a patient's motion, posture, arm height, activity level. Each of these parameters affects both blood pressure and PTT, and thus inclusion of them in an algorithm can improve the accuracy of these measurements, and consequently reduce false alarms/alerts associated with them.
[0111] Calculating Arm Height
[0112] To calculate a patient's arm height it is necessary to build a mathematical model representing the geometric orientation of the patient's arm, as detected with signals from the three accelerometers.
[0113] The algorithm for estimating a patient's motion and activity level begins with a calculation to determine their arm height. This is done using signals from accelerometers attached to the patient's bicep (i.e., with reference to
[0114] The algorithm determines a gravitational vector R.sub.GA at a later time by again sampling DC portions of ACC.sub.1-6. Once this is complete, the algorithm determines the angle □.sub.GA between the fixed arm vector R.sub.A and the gravitational vector R.sub.GA by calculating a dot product of the two vectors. As the patient moves their arm, signals measured by the two accelerometers vary, and are analyzed to determine a change in the gravitational vector R.sub.GA and, subsequently, a change in the angle □.sub.GA. The angle □.sub.GA can then be combined with an assumed, approximate length of the patient's arm (typically 0.8 m) to determine its height relative to a proximal joint, e.g. the elbow.
[0115]
.sub.B=r.sub.Bx{circumflex over (l)}+r.sub.ByĴ+r.sub.Bz{circumflex over (k)} (1)
At any given time, the gravitational vector R.sub.GB is determined from ACC waveforms (ACC.sub.1-3) using signals from the accelerometer 132b located near the patient's bicep, and is represented by equation (2) below:
.sub.GB[n]=y.sub.Bx[n]{circumflex over (l)}+y.sub.By[n]Ĵ+y.sub.Bz[n]{circumflex over (k)} (2)
Specifically, the CPU in the wrist-worn transceiver receives digitized signals representing the DC portion of the ACC.sub.1-3 signals measured with accelerometer 132b, as represented by equation (3) below, where the parameter n is the value (having units of g's) sampled directly from the DC portion of the ACC waveform:
y.sub.Bx[n]=y.sub.DC,Bicep,x[n]; y.sub.By[n]=y.sub.DC,Bicep,y[n]; y.sub.Bz[n]=y.sub.DC,Bicep,z[n] (3)
The cosine of the angle □.sub.GB separating the vector R.sub.B and the gravitational vector R.sub.GB is determined using equation (4):
The definition of the dot product of the two vectors R.sub.B and R.sub.GB is:
.sub.GB[n].Math.
.sub.B=(y.sub.Bx[n]×r.sub.Bx)+(y.sub.By[n]×r.sub.By)+(y.sub.Bz[n]×r.sub.Bz) (5)
and the definitions of the norms or magnitude of the vectors R.sub.B and R.sub.GB are:
Using the norm values for these vectors and the angle □.sub.GB separating them, as defined in equation (4), the height of the patient's elbow relative to their shoulder joint, as characterized by the accelerometer on their chest (h.sub.E) is determined using equation (8), where the length of the upper arm is estimated as L.sub.B:
h.sub.E[n]=−L.sub.B×cos(θ.sub.GB[n]) (8)
As is described in more detail below, equation (8) estimates the height of the patient's arm relative to their heart. And this, in turn, can be used to further improve the accuracy of PTT-based blood pressure measurements.
[0116] The height of the patient's wrist joint h.sub.W is calculated in a similar manner using DC components from the time-domain waveforms (ACC.sub.4-6) collected from the accelerometer 132a mounted within the wrist-worn transceiver. Specifically, the wrist vector R.sub.W is given by equation (9):
.sub.W=r.sub.Wx{circumflex over (l)}+r.sub.WyĴ+r.sub.Wz{circumflex over (k)} (9)
and the corresponding gravitational vector R.sub.GW is given by equation (10):
.sub.GW[n]=y.sub.Wx[n]{circumflex over (l)}+y.sub.Wy[n]Ĵ+y.sub.Wz[n]{circumflex over (k)} (10)
The specific values used in equation (10) are measured directly from the accelerometer 132a; they are represented as n and have units of g's, as defined below:
y.sub.Wx[n]=y.sub.DC,Wrist,x[n];y.sub.Wy[n]=y.sub.DC,Wrist,y[n];y.sub.Wz[n]=y.sub.DC,Wrist,z[n] (11)
The vectors R.sub.W and R.sub.GW described above are used to determine the cosine of the angle □.sub.GW separating them using equation (12):
The definition of the dot product between the vectors R.sub.W and R.sub.GW is:
.sub.GW[n].Math.
.sub.W=(y.sub.Wx[n]×r.sub.Wx)+(y.sub.Wy[n]×r.sub.Wy)+(y.sub.Wz[n]×r.sub.Wz) (13)
and the definitions of the norm or magnitude of both the vectors R.sub.W and R.sub.GW are:
∥.sub.GW[n]∥=√{square root over ((y.sub.Wx[n]).sup.2+(y.sub.Wy[n]).sup.2+(y.sub.Wz[n]).sup.2)} (14)
and
|.sub.W∥=√{square root over ((r.sub.Wx).sup.2+(r.sub.Wy).sup.2+(r.sub.Wz).sup.2)} (15)
The height of the patient's wrist h.sub.W can be calculated using the norm values described above in equations (14) and (15), the cosine value described in equation (12), and the height of the patient's elbow determined in equation (8):
h.sub.W[n]=h.sub.E[n]−L.sub.W×cos(θ.sub.GW[n]) (16)
In summary, the algorithm can use digitized signals from the accelerometers mounted on the patient's bicep and wrist, along with equations (8) and (16), to accurately determine the patient's arm height and position. As described below, these parameters can then be used to correct the PTT and provide a blood pressure calibration, similar to the cuff-based indexing measurement described above, that can further improve the accuracy of this measurement.
Calculating the Influence of Arm Height on Blood Pressure
[0117] A patient's blood pressure, as measured near the brachial artery, will vary with their arm height due to hydrostatic forces and gravity. This relationship between arm height and blood pressure enables two measurements: 1) a blood pressure ‘correction factor’, determined from slight changes in the patient's arm height, can be calculated and used to improve accuracy of the base blood pressure measurement; and 2) the relationship between PTT and blood pressure can be determined (like it is currently done using the indexing measurement) by measuring PTT at different arm heights, and calculating the change in PTT corresponding to the resultant change in height-dependent blood pressure. Specifically, using equations (8) and (16) above, and (21) below, an algorithm can calculate a change in a patient's blood pressure (□BP) simply by using data from two accelerometers disposed on the wrist and bicep. The □BP can be used as the correction factor. Exact blood pressure values can be estimated directly from arm height using an initial blood pressure value (determined, e.g., using the cuff-based module during an initial indexing measurement), the relative change in arm height, and the correction factor. This measurement can be performed, for example, when the patient is first admitted to the hospital. PTT determined at different arm heights provides multiple data points, each corresponding to a unique pair of blood pressure values determined as described above. The change in PTT values (□PTT) corresponds to changes in arm height.
[0118] From these data, the algorithm can calculate for each patient how blood pressure changes with PTT, i.e. □BP/□PTT. This relationship relates to features of the patient's cardiovascular system, and will evolve over time due to changes, e.g., in the patient's arterial tone and vascular compliance. Accuracy of the body-worn monitor's blood pressure measurement can therefore be improved by periodically calculating □BP/□PTT. This is best done by: 1) combining a cuff-based initial indexing measurement to set baseline values for SYS, DIA, and MAP, and then determining □BP/□PTT as described above; and 2) continually calculating □BP/□PTT by using the patient's natural motion, or alternatively using well-defined motions (e.g., raising and lower the arm to specific positions) as prompted at specific times by monitor's user interface.
[0119] Going forward, the body-worn monitor measures PTT, and can use this value and the relationship determined from the above-described calibration to convert this to blood pressure. All future indexing measurements can be performed on command (e.g., using audio or visual instructions delivered by the wrist-worn transceiver) using changes in arm height, or as the patient naturally raises and lowers their arm as they move about the hospital.
[0120] To determine the relationship between PTT, arm height, and blood pressure, the algorithm running on the wrist-worn transceiver is derived from a standard linear model shown in equation (17):
Assuming a constant velocity of the arterial pulse along an arterial pathway (e.g., the pathway extending from the heart, through the arm, to the base of the thumb):
the linear PTT model described in equation (17) becomes:
Equation (19) can be solved using piecewise integration along the upper 137 and lower 136 segments of the arm to yield the following equation for height-dependent PTT:
From equation (20) it is possible to determine a relative pressure change P.sub.rel induced in a cNIBP measurement using the height of the patient's wrist (h.sub.W) and elbow (h.sub.E):
As described above, P.sub.rel can be used to both calibrate the cNIBP measurement deployed by the body-worn monitor, or supply a height-dependent correction factor that reduces or eliminates the effect of posture and arm height on a PTT-based blood pressure measurement.
[0121]
[0122] Calculating a Patient's Posture
[0123] As described above in Tables 1A-C, a patient's posture can influence how the above-described system generates alarms/alerts. The body-worn monitor can determine a patient's posture using time-dependent ACC waveforms continuously generated from the three patient-worn accelerometers, as shown in .sub.CV is the vertical axis,
.sub.CH is the horizontal axis, and
.sub.CN is the normal axis. These axes must be identified relative to a ‘chest accelerometer coordinate space’ before the patient's posture can be determined.
[0124] The first step in this procedure is to identify alignment of .sub.CV in the chest accelerometer coordinate space. This can be determined in either of two approaches. In the first approach,
.sub.CV is assumed based on a typical alignment of the body-worn monitor relative to the patient. During manufacturing, these parameters are then preprogrammed into firmware operating on the wrist-worn transceiver. In this procedure it is assumed that accelerometers within the body-worn monitor are applied to each patient with essentially the same configuration. In the second approach,
.sub.CV is identified on a patient-specific basis. Here, an algorithm operating on the wrist-worn transceiver prompts the patient (using, e.g., video instruction operating on the display, or audio instructions transmitted through the speaker) to assume a known position with respect to gravity (e.g., standing up with arms pointed straight down). The algorithm then calculates
.sub.CV from DC values corresponding to the x, y, and z axes of the chest accelerometer while the patient is in this position. This case, however, still requires knowledge of which arm (left or right) the monitor is worn on, as the chest accelerometer coordinate space can be rotated by 180 degrees depending on this orientation. A medical professional applying the monitor can enter this information using the GUI, described above. This potential for dual-arm attachment requires a set of two pre-determined vertical and normal vectors which are interchangeable depending on the monitor's location. Instead of manually entering this information, the arm on which the monitor is worn can be easily determined following attachment using measured values from the chest accelerometer values, with the assumption that
.sub.CV is not orthogonal to the gravity vector.
[0125] The second step in the procedure is to identify the alignment of .sub.CN in the chest accelerometer coordinate space. The monitor can determine this vector, similar to the way it determines
.sub.CV, with one of two approaches. In the first approach the monitor assumes a typical alignment of the chest-worn accelerometer on the patient. In the second approach, the alignment is identified by prompting the patient to assume a known position with respect to gravity. The monitor then calculates
.sub.CN from the DC values of the time-dependent ACC waveform.
[0126] The third step in the procedure is to identify the alignment of .sub.CH in the chest accelerometer coordinate space. This vector is typically determined from the vector cross product of
.sub.CV and
.sub.CN, or it can be assumed based on the typical alignment of the accelerometer on the patient, as described above.
[0127] .sub.CV 140,
.sub.CN 141, and
.sub.CH 142 and a gravitational vector
.sub.G 143 measured from a moving patient in a chest accelerometer coordinate space 139. The body-worn monitor continually determines a patient's posture from the angles separating these vectors. Specifically, the monitor continually calculates
.sub.G 143 for the patient using DC values from the ACC waveform measured by the chest accelerometer. From this vector, the body-worn monitor identifies angles (θ.sub.VG, θ.sub.NG, and θ.sub.HG) separating it from
.sub.CV 140,
.sub.CN 141, and
.sub.CH 142. The body-worn monitor then compares these three angles to a set of predetermine posture thresholds to classify the patient's posture.
[0128] The derivation of this algorithm is as follows. Based on either an assumed orientation or a patient-specific calibration procedure described above, the alignment of .sub.CV in the chest accelerometer coordinate space is given by:
.sub.CV=r.sub.CVx{circumflex over (l)}+r.sub.CVyĴ+r.sub.CVz{circumflex over (k)} (22)
At any given moment, .sub.G is constructed from DC values of the ACC waveform from the chest accelerometer along the x, y, and z axes:
.sub.G[n]=y.sub.Cx[n]{circumflex over (l)}+y.sub.Cy[n]Ĵ+y.sub.Cz[n]{circumflex over (k)} (23)
Equation (24) shows specific components of the ACC waveform used for this calculation:
y.sub.Cx[n]=y.sub.DC,chest,x[n];y.sub.Cy[n]=y.sub.DC,chest,y[n];y.sub.Cz[n]=y.sub.DC,chest,z[n] (24)
The angle between .sub.CV and
.sub.G is given by equation (25):
where the dot product of the two vectors is defined as:
.sub.G[n].Math.
.sub.CV=(y.sub.Cx[n]×r.sub.CVx)+(y.sub.Cy[n]×r.sub.CVy)+(y.sub.Cz[n]×r.sub.CVz) (26)
The definition of the norms of .sub.G and
.sub.CV are given by equations (27) and (28):
∥.sub.G[n]∥=√{square root over ((y.sub.Cx[n]).sup.2+(y.sub.Cy[n]).sup.2+(y.sub.Cz[n]).sup.2)} (27)
∥.sub.CV∥=√{square root over ((r.sub.CVx).sup.2+(r.sub.CVy).sup.2+(r.sub.CVz).sup.2)} (28)
[0129] As shown in equation (29), the monitor compares the vertical angle θ.sub.VG to a threshold angle to determine whether the patient is vertical (i.e. standing upright) or lying down:
if θ.sub.VG≤45° then Torso State=0, the patient is upright (29)
If the condition in equation (29) is met the patient is assumed to be upright, and their torso state, which is a numerical value equated to the patient's posture, is equal to 0. The torso state is processed by the body-worn monitor to indicate, e.g., a specific icon corresponding to this state, such as icon 105a in
[0130] The angle θ.sub.NG between .sub.CN and
.sub.G determines if the patient is lying in the supine position (chest up), prone position (chest down), or on their side. Based on either an assumed orientation or a patient-specific calibration procedure, as described above, the alignment of
.sub.CN is given by equation (30), where i, j, k represent the unit vectors of the x, y, and z axes of the chest accelerometer coordinate space respectively:
.sub.CN=r.sub.CNx{circumflex over (l)}+r.sub.CNyĴ+r.sub.CNz{circumflex over (k)} (30)
The angle between .sub.CN and
.sub.G determined from DC values extracted from the chest accelerometer ACC waveform is given by equation (31):
The body-worn monitor determines the normal angle θ.sub.NG and then compares it to a set of predetermined threshold angles to determine which position the patient is lying in, as shown in equation (32):
if θ.sub.NG≤35° then Torso State=1, the patient is supine
if θ.sub.NG≥135° then Torso State=2, the patient is prone (32)
Icons corresponding to these torso states are shown, for example, as icons 105h and 105g in
[0131] The alignment of .sub.CH is determined using either an assumed orientation, or from the vector cross-product of
.sub.CV and
.sub.CN as given by equation (33), where i, j, k represent the unit vectors of the x, y, and z axes of the accelerometer coordinate space respectively. Note that the orientation of the calculated vector is dependent on the order of the vectors in the operation. The order below defines the horizontal axis as positive towards the right side of the patient's body.
.sub.CH=r.sub.CVx{circumflex over (l)}+r.sub.CVyĴ+r.sub.CVz{circumflex over (k)}=
.sub.CV×
.sub.CN (33)
The angle θ.sub.HG between .sub.CH and
.sub.G is determined using equation (34):
The monitor compares this angle to a set of predetermined threshold angles to determine if the patient is lying on their right or left side, as given by equation (35):
if θ.sub.HG≥90° then Torso State=3, the patient is on their right side
if θ.sub.NG<90° then Torso State=4, the patient is on their left side (35)
Table 4 describes each of the above-described postures, along with a corresponding numerical torso state used to render, e.g., a particular icon:
TABLE-US-00006 TABLE 4 postures and their corresponding torso states Posture Torso State Upright 0 supine: lying on back 1 prone: lying on chest 2 lying on right side 3 lying on left side 4 undetermined posture 5 .sub.G and the various quantized torso states for the patient, as shown in the graph 151 in
[0132] Calculating a Patient's Activity
[0133] An algorithm can process information generated by the accelerometers described above to determine a patient's specific activity (e.g., walking, resting, convulsing), which is then used to reduce the occurrence of false alarms. This classification is done using a ‘logistic regression model classifier’, which is a type of classifier that processes continuous data values and maps them to an output that lies on the interval between 0 and 1. A classification ‘threshold’ is then set as a fractional value within this interval. If the model output is greater than or equal to this threshold, the classification is declared ‘true’, and a specific activity state can be assumed for the patient. If the model output falls below the threshold, then the specific activity is assumed not to take place.
[0134] This type of classification model offers several advantages. First, it provides the ability to combine multiple input variables into a single model, and map them to a single probability ranging between 0 and 1. Second, the threshold that allows the maximum true positive outcomes and the minimum false positive outcomes can be easily determined from a ROC curve, which in turn can be determined using empirical experimentation and data. Third, this technique requires minimal computation.
[0135] The formula for the logistic regression model is given by equation (36) and is used to determine the outcome, P, for a set of buffered data:
The logit variable z is defined in terms of a series of predictors (x.sub.i), each affected by a specific type of activity, and determined by the three accelerometers worn by the patient, as shown in equation (37):
z=b.sub.0+b.sub.1x.sub.1+b.sub.2x.sub.2+ . . . +b.sub.mx.sub.m (37)
In this model, the regression coefficients (b.sub.i, i=0, 1, . . . , m) and the threshold (P.sub.th) used in the patient motion classifier and signal corruption classifiers are determined empirically from data collected on actual subjects. The classifier results in a positive outcome as given in equation (38) if the logistic model output, P, is greater than the predetermined threshold, P.sub.th:
If P≥P.sub.th then Classifier State=1 (38)
[0136]
TABLE-US-00007 TABLE 5 predictor variables and their relationship to the accelerometer signal predictor variable Description x.sub.1 normalized power of the AC component of the time-dependent accelerometer signal x.sub.2 average arm angle measured while time-dependent accelerometer signal is collected x.sub.3 standard deviation of the arm angle while time-dependent accelerometer signal is collected x.sub.4 fractional power of the AC component of the frequency-dependent accelerometer signal between 0.5-1.0 Hz x.sub.5 fractional power of the AC component of the frequency-dependent accelerometer signal between 1.0-2.0 Hz x.sub.6 fractional power of the AC component of the frequency-dependent accelerometer signal between 2.0-3.0 Hz x.sub.7 fractional power of the AC component of the frequency-dependent accelerometer signal between 3.0-4.0 Hz x.sub.8 fractional power of the AC component of the frequency-dependent accelerometer signal between 4.0-5.0 Hz x.sub.9 fractional power of the AC component of the frequency-dependent accelerometer signal between 5.0-6.0 Hz x.sub.10 fractional power of the AC component of the frequency-dependent accelerometer signal between 6.0-7.0 Hz
The predictor variables described in Table 5 are typically determined from ACC signals generated by accelerometers deployed in locations that are most affected by patient motion. Such accelerometers are typically mounted directly on the wrist-worn transceiver, and on the bulkhead connector attached to the patient's arm. The normalized signal power (x.sub.1) for the AC components (y.sub.W,i, i=x,y,z) calculated from the ACC is shown in equation (39), where F.sub.s denotes the signal sampling frequency, N is the size of the data buffer, and x.sub.norm is a predetermined power value:
The average arm angle predictor value (x.sub.2) was determined using equation (40):
Note that, for this predictor value, it is unnecessary to explicitly determine the angle □.sub.GW using an arccosine function, and the readily available cosine value calculated in equation (12) acts as a surrogate parameter indicating the mean arm angle. The predictor value indicating the standard deviation of the arm angle (x.sub.3) was determined using equation (41) using the same assumptions for the angle □.sub.GW as described above:
[0137] The remaining predictor variables (x.sub.4-x.sub.10) are determined from the frequency content of the patient's motion, determined from the power spectrum of the time-dependent accelerometer signals, as indicated in
X.sub.W[m]=a.sub.m+ib.sub.m (42)
Once the FFT is determined from the entire time-domain ACC waveform, the fractional power in the designated frequency band is given by equation (43), which is based on Parseval's theorem. The term mStart refers to the FFT coefficient index at the start of the frequency band of interest, and the term mEnd refers to the FFT coefficient index at the end of the frequency band of interest:
Finally, the formula for the total signal power, P.sub.T, is given in equation (44):
[0138] As described above, to accurately estimate a patient's activity level, predictor values x.sub.1-x.sub.10 defined above are measured from a variety of subjects selected from a range of demographic criteria (e.g., age, gender, height, weight), and then processed using predetermined regression coefficients (b.sub.j) to calculate a logit variable (defined in equation (37)) and the corresponding probability outcome (defined in equation (36)). A threshold value is then determined empirically from an ROC curve. The classification is declared true if the model output is greater than or equal to the threshold value. During an actual measurement, an accelerometer signal is measured and then processed as described above to determine the predictor values. These parameters are used to determine the logit and corresponding probability, which is then compared to a threshold value to estimate the patient's activity level.
[0139]
[0140]
[0141] ROC curves similar to those shown in
[0142] Hardware System for Body-Worn Monitor
[0143]
[0144] The body-worn monitor 10 features a wrist-worn transceiver 272, described in more detail in
[0145] To determine ACC waveforms the body-worn monitor 10 features three separate accelerometers located at different portions on the patient's arm. The first accelerometer is surface-mounted on a circuit board in the wrist-worn transceiver 272 and measures signals associated with movement of the patient's wrist. The second accelerometer is included in a small bulkhead portion 296 included along the span of the cable 286. During a measurement, a small piece of disposable tape, similar in size to a conventional bandaid, affixes the bulkhead portion 296 to the patient's arm. In this way the bulkhead portion 296 serves two purposes: 1) it measures a time-dependent ACC waveform from the mid-portion of the patient's arm, thereby allowing their posture and arm height to be determined as described in detail above; and 2) it secures the cable 286 to the patient's arm to increase comfort and performance of the body-worn monitor 10, particularly when the patient is ambulatory.
[0146] The cuff-based module 285 features a pneumatic system 276 that includes a pump, valve, pressure fittings, pressure sensor, analog-to-digital converter, microcontroller, and rechargeable battery. During an indexing measurement, it inflates a disposable cuff 284 and performs two measurements according to the composite technique: 1) it performs an inflation-based measurement of oscillometry to determine values for SYS, DIA, and MAP; and 2) it determines a patient-specific relationship between PTT and MAP. These measurements are performed according to the composite technique, and are described in detail in the above-referenced patent application entitled: ‘VITAL SIGN MONITOR FOR MEASURING BLOOD PRESSURE USING OPTICAL, ELECTRICAL, AND PRESSURE WAVEFORMS’ (U.S. Ser. No. 12/138,194; filed Jun. 12, 2008), the contents of which have been previously incorporated herein by reference.
[0147] The cuff 284 within the cuff-based pneumatic system 285 is typically disposable and features an internal, airtight bladder that wraps around the patient's bicep to deliver a uniform pressure field. During the indexing measurement, pressure values are digitized by the internal analog-to-digital converter, and sent through a cable 286 according to the CAN protocol, along with SYS, DIA, and MAP blood pressures, to the wrist-worn transceiver 272 for processing as described above. Once the cuff-based measurement is complete, the cuff-based module 285 is removed from the patient's arm and the cable 286 is disconnected from the wrist-worn transceiver 272. cNIBP is then determined using PTT, as described in detail above.
[0148] To determine an ECG, the body-worn monitor 10 features a small-scale, three-lead ECG circuit integrated directly into a bulkhead 274 that terminates an ECG cable 282. The ECG circuit features an integrated circuit that collects electrical signals from three chest-worn ECG electrodes 278a-c connected through cables 280a-c. The ECG electrodes 278a-c are typically disposed in a conventional ‘Einthoven's Triangle’ configuration which is a triangle-like orientation of the electrodes 278a-c on the patient's chest that features three unique ECG vectors. From these electrical signals the ECG circuit determines up to three ECG waveforms, which are digitized using an analog-to-digital converter mounted proximal to the ECG circuit, and sent through a five-wire cable 282 to the wrist-worn transceiver 272 according to the CAN protocol. There, the ECG is processed with the PPG to determine the patient's blood pressure. Heart rate and respiratory rate are determined directly from the ECG waveform using known algorithms, such as those described in the following reference, the contents of which are incorporated herein by reference: ‘ECG Beat Detection Using Filter Banks’, Afonso et al., IEEE Trans. Biomed Eng., 46:192-202 (1999). The cable bulkhead 274 also includes an accelerometer that measures motion associated with the patient's chest as described above.
[0149] There are several advantages of digitizing ECG and ACC waveforms prior to transmitting them through the cable 282. First, a single transmission line in the cable 282 can transmit multiple digital waveforms, each generated by different sensors. This includes multiple ECG waveforms (corresponding, e.g., to vectors associated with three, five, and twelve-lead ECG systems) from the ECG circuit mounted in the bulkhead 274, along with waveforms associated with the x, y, and z axes of accelerometers mounted in the bulkheads 275, 296. Limiting the transmission line to a single cable reduces the number of wires attached to the patient, thereby decreasing the weight and cable-related clutter of the body-worn monitor. Second, cable motion induced by an ambulatory patient can change the electrical properties (e.g. electrical impendence) of its internal wires. This, in turn, can add noise to an analog signal and ultimately the vital sign calculated from it. A digital signal, in contrast, is relatively immune to such motion-induced artifacts.
[0150] More sophisticated ECG circuits can plug into the wrist-worn transceiver to replace the three-lead system shown in
[0151]
[0152] As described above, the transceiver 272 features three CAN connectors 204a-c on the side of its upper portion, each which supports the CAN protocol and wiring schematics, and relays digitized data to the internal CPU. Digital signals that pass through the CAN connectors include a header that indicates the specific signal (e.g. ECG, ACC, or pressure waveform from the cuff-based module) and the sensor from which the signal originated. This allows the CPU to easily interpret signals that arrive through the CAN connectors 204a-c, and means that these connectors are not associated with a specific cable. Any cable connecting to the transceiver can be plugged into any connector 204a-c. As shown in
[0153] The second CAN connector 204b shown in
[0154] The final CAN connector 204c can be used for an ancillary device, e.g. a glucometer, infusion pump, body-worn insulin pump, ventilator, or end-tidal CO.sub.2 delivery system. As described above, digital information generated by these systems will include a header that indicates their origin so that the CPU can process them accordingly.
[0155] The transceiver includes a speaker 201 that allows a medical professional to communicate with the patient using a voice over Internet protocol (VOIP). For example, using the speaker 101 the medical professional could query the patient from a central nursing station or mobile phone connected to a wireless, Internet-based network within the hospital. Or the medical professional could wear a separate transceiver similar to the shown in
[0156] In addition to those methods described above, a number of additional methods can be used to calculate blood pressure from the optical and electrical waveforms. These are described in the following co-pending patent applications, the contents of which are incorporated herein by reference: 1) CUFFLESS BLOOD-PRESSURE MONITOR AND ACCOMPANYING WIRELESS, INTERNET-BASED SYSTEM (U.S. Ser. No. 10/709,015; filed Apr. 7, 2004); 2) CUFFLESS SYSTEM FOR MEASURING BLOOD PRESSURE (U.S. Ser. No. 10/709,014; filed Apr. 7, 2004); 3) CUFFLESS BLOOD PRESSURE MONITOR AND ACCOMPANYING WEB SERVICES INTERFACE (U.S. Ser. No. 10/810,237; filed Mar. 26, 2004); 4) CUFFLESS BLOOD PRESSURE MONITOR AND ACCOMPANYING WIRELESS MOBILE DEVICE (U.S. Ser. No. 10/967,511; filed Oct. 18, 2004); 5) BLOOD PRESSURE MONITORING DEVICE FEATURING A CALIBRATION-BASED ANALYSIS (U.S. Ser. No. 10/967,610; filed Oct. 18, 2004); 6) PERSONAL COMPUTER-BASED VITAL SIGN MONITOR (U.S. Ser. No. 10/906,342; filed Feb. 15, 2005); 7) PATCH SENSOR FOR MEASURING BLOOD PRESSURE WITHOUT A CUFF (U.S. Ser. No. 10/906,315; filed Feb. 14, 2005); 8) PATCH SENSOR FOR MEASURING VITAL SIGNS (U.S. Ser. No. 11/160,957; filed Jul. 18, 2005); 9) WIRELESS, INTERNET-BASED SYSTEM FOR MEASURING VITAL SIGNS FROM A PLURALITY OF PATIENTS IN A HOSPITAL OR MEDICAL CLINIC (U.S. Ser. No. 11/162,719; filed Sep. 9, 2005); 10) HAND-HELD MONITOR FOR MEASURING VITAL SIGNS (U.S. Ser. No. 11/162,742; filed Sep. 21, 2005); 11) CHEST STRAP FOR MEASURING VITAL SIGNS (U.S. Ser. No. 11/306,243; filed Dec. 20, 2005); 12) SYSTEM FOR MEASURING VITAL SIGNS USING AN OPTICAL MODULE FEATURING A GREEN LIGHT SOURCE (U.S. Ser. No. 11/307,375; filed Feb. 3, 2006); 13) BILATERAL DEVICE, SYSTEM AND METHOD FOR MONITORING VITAL SIGNS (U.S. Ser. No. 11/420,281; filed May 25, 2006); 14) SYSTEM FOR MEASURING VITAL SIGNS USING BILATERAL PULSE TRANSIT TIME (U.S. Ser. No. 11/420,652; filed May 26, 2006); 15) BLOOD PRESSURE MONITOR (U.S. Ser. No. 11/530,076; filed Sep. 8, 2006); 16) TWO-PART PATCH SENSOR FOR MONITORING VITAL SIGNS (U.S. Ser. No. 11/558,538; filed Nov. 10, 2006); and, 17) MONITOR FOR MEASURING VITAL SIGNS AND RENDERING VIDEO IMAGES (U.S. Ser. No. 11/682,177; filed Mar. 5, 2007).
[0157] Other embodiments are also within the scope of the invention. For example, other techniques, such as conventional oscillometry measured during deflation, can be used to determine SYS for the above-described algorithms.
[0158] Still other embodiments are within the scope of the following claims.